I provide care in the following areas: advanced heart failure/transplant, medical ventricular assist device, general cardiology, electrophysiology, and pulmonary hypertension.
Pharmacy School Attended: University of Michigan (2011)
- PGY1 Pharmacy Residency: University of Michigan
- PGY2 Cardiology: University of Michigan
Areas of Interest
Pulmonary hypertension, heart failure/transplant, mechanical circulatory support, anticoagulation
A Case Report of a Patient with Pulmonary Arterial Hypertension Transitioned from Inhaled Iloprost to Selexipag: Verlinden NJ, Walter C, Raina A, Benza R. J Pharm Pract. 2020 Sept 10; Online ahead of print.
PH Professional Network: Bridging the Gap: A Multidisciplinary Approach to Transitions of Care: McDevitt S, Walter C. Advances in Pulmonary Hypertension. 2019; 18(3):103-107.
Transition from Oral Treprostinil to Selexipag in a Patient with Pulmonary Arterial Hypertension: Verlinden NJ, Walter C, Kanwar M, Raina A. Ann Pharmacother. 2019 Jul;53(7):764-765.
Use of an implantable wireless pulmonary pressure monitor during transition of therapy in pulmonary arterial hypertension: Airhart S, Verlinden N, Badie N, Raina A, Benza R. J Heart Lung Transplant. 2019 Feb;38(2):227-230. Acknowledgement: Claire Walter
Chapter: Pulmonary Arterial Hypertension: Pogue, KT and Walter CP. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program (PSAP), 2016 Book 1. Cardiology. Lenexa, KS: American College of Clinical Pharmacy, 2016:61-83.
Targeting heart failure with preserved ejection fraction: current status and future prospects: Kanwar M, Walter C, Clarke M, Patarroyo-Aponte M. Vasc Health Risk Manag. 2016 Apr;12:129-41.
Management of pulmonary hypertension due to heart failure with preserved ejection fraction: Kanwar M, Tedford RJ, Agarwal R, Clarke MM, Walter C, Sokos G, Murali S, Benza RL. Curr Hypertens Rep. 2014 Dec;16(12):501.
Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents: Walter CP, Bleske BE, Dorsch MP. J Clin Pharm Ther. 2014 Oct;39(5):475-84.
Macitentan (Opsumit) for the treatment of pulmonary arterial hypertension: Clarke M, Walter C, Agarwal R, Kanwar M, Benza RL. Expert Rev Clin Pharmacol. 2014 Jul;7(4)415-21.
Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons. Chattopadhyay M, Walter C, Mata M, Fink DJ. Brain. 2009 Apr; 132 (Pt 4): 879-88.